找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Breast Cancer Research and Treatment; Innovative Concepts Ouissam Al Jarroudi,Khalid El Bairi,Giuseppe Curig Book 2023 The Editor(s) (if ap

[复制链接]
楼主: Corrugate
发表于 2025-3-28 16:24:34 | 显示全部楼层
发表于 2025-3-28 22:24:24 | 显示全部楼层
发表于 2025-3-28 23:49:35 | 显示全部楼层
发表于 2025-3-29 06:42:18 | 显示全部楼层
https://doi.org/10.1007/978-3-319-99510-6to discuss the value and the role of integrated oncological care in the era of oncology sub-specializations. Additionally, it sheds light on how the harmonization across the health providers can enhance patient care in this setting.
发表于 2025-3-29 11:19:22 | 显示全部楼层
发表于 2025-3-29 13:40:15 | 显示全部楼层
发表于 2025-3-29 17:09:02 | 显示全部楼层
发表于 2025-3-29 21:40:14 | 显示全部楼层
https://doi.org/10.1007/978-981-15-9158-7t options based on tumour patterns and a patient-centred approach. A proper patient’s selection is crucial to derive maximal benefits from a treatment strategy and emerging biomarkers should be integrated along with the HER2 status, which is currently the only validated biomarker in the context of H
发表于 2025-3-30 00:58:54 | 显示全部楼层
https://doi.org/10.1007/978-981-15-9158-7and many trials specifically designed for this population are currently ongoing. The BC research community needs to address this call with the final aim of improving the efficacy of systemic therapy in CNS compartment and ultimately preventing the occurrence of BM.
发表于 2025-3-30 06:47:04 | 显示全部楼层
https://doi.org/10.1007/978-981-15-9158-7ing. The aim of this chapter is to review all types of cardiotoxic manifestations related to novel and old agents approved for treatment of BC patients including chemotherapy, anti-HER2 agents, cyclin-dependent kinase 4/6 inhibitors, PolyADP-ribose polymerase (PARP) inhibitors, antiangiogenic drugs
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-29 23:52
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表